In recent years, TRPV1-targeted drugs have received much attention in inflammatory arthritis, e.g. RA, OA, gouty arthritis, etc. Data on the modulation of the TRPV1 channel for arthritis are summarised in Table 1. Here, TRPV1 is linked to arthritic joint disease.